Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018

  • ID: 4529319
  • Drug Pipelines
  • 265 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Abion Inc
  • Astex Pharmaceuticals Inc
  • Genexine Inc
  • Juno Therapeutics Inc
  • Oxford Vacmedix UK Ltd
  • Sirnaomics Inc
  • MORE
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018

Summary:

This latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape.

Human papillomavirus (HPV) is the most common viral infection of the reproductive tract. Human papillomavirus (HPV) has been found to be associated with several types of cancer. Risk factors include smoking, weakened immune system, long-term oral contraceptive use and chronic inflammation. Human papillomavirus (HPV) associated cancer have no symptoms until it is quite advanced, very serious and hard to treat.

Report Highlights:

This latest pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Human Papillomavirus (HPV) Associated Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Human Papillomavirus (HPV) Associated Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 18, 12, 39, 3 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 3, 1, 11 and 2 molecules, respectively.

Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Human Papillomavirus (HPV) Associated Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Human Papillomavirus (HPV) Associated Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Human Papillomavirus (HPV) Associated Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Human Papillomavirus (HPV) Associated Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Human Papillomavirus (HPV) Associated Cancer (Oncology)
Reasons for Purchase:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Human Papillomavirus (HPV) Associated Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abion Inc
  • Astex Pharmaceuticals Inc
  • Genexine Inc
  • Juno Therapeutics Inc
  • Oxford Vacmedix UK Ltd
  • Sirnaomics Inc
  • MORE
Introduction

Human Papillomavirus (HPV) Associated Cancer - Overview

Human Papillomavirus (HPV) Associated Cancer - Therapeutics Development

Human Papillomavirus (HPV) Associated Cancer - Therapeutics Assessment

Human Papillomavirus (HPV) Associated Cancer - Companies Involved in Therapeutics Development

Human Papillomavirus (HPV) Associated Cancer - Drug Profiles

Human Papillomavirus (HPV) Associated Cancer - Dormant Projects

Human Papillomavirus (HPV) Associated Cancer - Discontinued Products

Human Papillomavirus (HPV) Associated Cancer - Product Development Milestones

Appendix

List of Tables

Table 1: Number of Products under Development for Human Papillomavirus (HPV) Associated Cancer, H1 2018

Table 2: Number of Products under Development by Companies, H1 2018

Table 3: Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Table 4: Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Table 5: Number of Products under Development by Companies, H1 2018 (Contd..3), H1 2018

Table 6: Number of Products under Development by Universities/Institutes, H1 2018

Table 7: Products under Development by Companies, H1 2018

Table 8: Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Table 9: Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Table 10: Products under Development by Companies, H1 2018 (Contd..3), H1 2018

Table 11: Products under Development by Universities/Institutes, H1 2018

Table 12: Number of Products by Stage and Target, H1 2018

Table 13: Number of Products by Stage and Mechanism of Action, H1 2018

Table 14: Number of Products by Stage and Route of Administration, H1 2018

Table 15: Number of Products by Stage and Molecule Type, H1 2018

Table 16: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Abion Inc, H1 2018

Table 17: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Abivax SA, H1 2018

Table 18: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Admedus Ltd, H1 2018

Table 19: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Advaxis Inc, H1 2018

Table 20: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Amgen Inc, H1 2018

Table 21: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Antigen Express Inc, H1 2018

Table 22: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Astex Pharmaceuticals Inc, H1 2018

Table 23: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Atara Biotherapeutics Inc, H1 2018

Table 24: Human Papillomavirus (HPV) Associated Cancer - Pipeline by BioNTech AG, H1 2018

Table 25: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Cancer Research Technology Ltd, H1 2018

Table 26: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Denceptor Therapeutics Ltd, H1 2018

Table 27: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Etubics Corp, H1 2018

Table 28: Human Papillomavirus (HPV) Associated Cancer - Pipeline by EyeGene Inc, H1 2018

Table 29: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Formune SL, H1 2018

Table 30: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Genexine Inc, H1 2018

Table 31: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Hookipa Biotech AG, H1 2018

Table 32: Human Papillomavirus (HPV) Associated Cancer - Pipeline by iBio Inc, H1 2018

Table 33: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Immunovaccine Inc, H1 2018

Table 34: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Inovio Pharmaceuticals Inc, H1 2018

Table 35: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Iovance Biotherapeutics Inc, H1 2018

Table 36: Human Papillomavirus (HPV) Associated Cancer - Pipeline by ISA Pharmaceuticals BV, H1 2018

Table 37: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Johnson & Johnson, H1 2018

Table 38: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Juno Therapeutics Inc, H1 2018

Table 39: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Karyopharm Therapeutics Inc, H1 2018

Table 40: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Kite Pharma Inc, H1 2018

Table 41: Human Papillomavirus (HPV) Associated Cancer - Pipeline by MedImmune LLC, H1 2018

Table 42: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Merck KGaA, H1 2018

Table 43: Human Papillomavirus (HPV) Associated Cancer - Pipeline by NeoImmuneTech Inc, H1 2018

Table 44: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Onconova Therapeutics Inc, H1 2018

Table 45: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Oxford Vacmedix UK Ltd, H1 2018

Table 46: Human Papillomavirus (HPV) Associated Cancer - Pipeline by PDS Biotechnology Corp, H1 2018

Table 47: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Profectus BioSciences Inc, H1 2018

Table 48: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Rottapharm Biotech Srl, H1 2018

Table 49: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Selecta Biosciences Inc, H1 2018

Table 50: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Shantha Biotechnics Pvt Ltd, H1 2018

Table 51: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Shuttle Pharmaceuticals Inc, H1 2018

Table 52: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Sierra Oncology Inc, H1 2018

Table 53: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Sirnaomics Inc, H1 2018

Table 54: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Theravectys SA, H1 2018

Table 55: Human Papillomavirus (HPV) Associated Cancer - Pipeline by THEVAX Genetics Vaccine USA Inc, H1 2018

Table 56: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Touchlight Genetics Ltd, H1 2018

Table 57: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Transgene SA, H1 2018

Table 58: Human Papillomavirus (HPV) Associated Cancer - Pipeline by UbiVac LLC, H1 2018

Table 59: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Vaccibody AS, H1 2018

Table 60: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Vault Pharma Inc, H1 2018

Table 61: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Vectorite Biomedical Inc, H1 2018

Table 62: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Virometix AG, H1 2018

Table 63: Human Papillomavirus (HPV) Associated Cancer - Pipeline by VLPbio, H1 2018

Table 64: Human Papillomavirus (HPV) Associated Cancer - Pipeline by Vyriad Inc, H1 2018

Table 65: Human Papillomavirus (HPV) Associated Cancer - Dormant Projects, H1 2018

List of Figures

Figure 1: Number of Products under Development for Human Papillomavirus (HPV) Associated Cancer, H1 2018

Figure 2: Number of Products under Development by Companies, H1 2018

Figure 3: Number of Products under Development by Universities/Institutes, H1 2018

Figure 4: Number of Products by Top 10 Targets, H1 2018

Figure 5: Number of Products by Stage and Top 10 Targets, H1 2018

Figure 6: Number of Products by Top 10 Mechanism of Actions, H1 2018

Figure 7: Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018

Figure 8: Number of Products by Top 10 Routes of Administration, H1 2018

Figure 9: Number of Products by Stage and Top 10 Routes of Administration, H1 2018

Figure 10: Number of Products by Top 10 Molecule Types, H1 2018

Figure 11: Number of Products by Stage and Top 10 Molecule Types, H1
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abion Inc
  • Abivax SA
  • Admedus Ltd
  • Advaxis Inc
  • Amgen Inc
  • Antigen Express Inc
  • Astex Pharmaceuticals Inc
  • Atara Biotherapeutics Inc
  • BioNTech AG
  • Cancer Research Technology Ltd
  • Denceptor Therapeutics Ltd
  • Etubics Corp
  • EyeGene Inc
  • Formune SL
  • Genexine Inc
  • Hookipa Biotech AG
  • iBio Inc
  • Immunovaccine Inc
  • Inovio Pharmaceuticals Inc
  • Iovance Biotherapeutics Inc
  • ISA Pharmaceuticals BV
  • Johnson & Johnson
  • Juno Therapeutics Inc
  • Karyopharm Therapeutics Inc
  • Kite Pharma Inc
  • MedImmune LLC
  • Merck KGaA
  • NeoImmuneTech Inc
  • Onconova Therapeutics Inc
  • Oxford Vacmedix UK Ltd
  • PDS Biotechnology Corp
  • Profectus BioSciences Inc
  • Rottapharm Biotech Srl
  • Selecta Biosciences Inc
  • Shantha Biotechnics Pvt Ltd
  • Shuttle Pharmaceuticals Inc
  • Sierra Oncology Inc
  • Sirnaomics Inc
  • Theravectys SA
  • THEVAX Genetics Vaccine USA Inc
  • Touchlight Genetics Ltd
  • Transgene SA
  • UbiVac LLC
  • Vaccibody AS
  • Vault Pharma Inc
  • Vectorite Biomedical Inc
  • Virometix AG
  • VLPbio
  • Vyriad Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll